Billy Evans, companion of Theranos founder Elizabeth Holmes, is engaged on a brand new startup that seeks to ship “human well being optimization” by way of blood testing, according to The New York Times.
The Occasions reportedly spoke to 2 buyers pitched on the startup, referred to as Haemanthus, and likewise seen a few of Haemanthus’ advertising and marketing supplies.
In these supplies, the corporate says it has developed a machine that makes use of lasers to research blood, saliva, and urine samples to detect most cancers and infections. It reportedly plans to begin with pet well being earlier than increasing to people, and it seeks to lift greater than $50 million.
The pitch echoes that for Theranos, which promised to conduct a wide range of medical checks on tiny quantities of blood drawn from pricked fingers. In 2022, Holmes (with whom Evans has two youngsters) was sentenced to 11 years in jail for defrauding buyers, although she stated in a latest interview that she stays “fully dedicated to my dream of constructing reasonably priced healthcare options obtainable to everybody.”
Early Fb investor Jim Breyer instructed The Occasions that his group was requested to speculate however declined “for lots of the identical causes we handed twice on Theranos.”
